The observation of reduced and fragmented sleep in Grm2/3-/- mice implies—but does not prove—that abnormal group II metabotropic glutamate receptor signalling may be relevant to sleep disruption in schizophrenia. The gene discussed is GRM2; the disease is schizophrenia.